drug

vimseltinib

1 story · latest Aug 4, 2026

Status: FDA approved Feb 2025 · NDA219304
Brand: Romvimza

Relationships

Developed by Ono Pharmaceutical

Timeline

Deciphera registers Phase 1 drug interaction study of vimseltinib with dabigatran

Aug 4Trial updateDabigatran Ono Pharmaceutical

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.